Hepatocyte Receptor
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Analysis of the Role of Hepatocyte SLAMF3 Receptor and Drug Resistance Proteins (MDR) in Resistance to Treatment With Sorafenib in CHC Patients (NCT03113604) | Centre Hospitalier Universitaire, Amiens | 2015-11-20 |
Track Hepatocyte Receptor automatically
Every clearance here is in the API, with alerts when new ones post.